Adaptimmune Therapeutics plc (ADAP)
Largest Insider Buys in Sector
ADAP Stock Price History Chart
ADAP Stock Performance
About Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS); in phase II clinical trials with SPEARHEAD-2 for patients with head and …
Insider Activity of Adaptimmune Therapeutics plc
Over the last 12 months, insiders at Adaptimmune Therapeutics plc have bought $0 and sold $147,201 worth of Adaptimmune Therapeutics plc stock.
On average, over the past 5 years, insiders at Adaptimmune Therapeutics plc have bought $10.09M and sold $1.87M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 39,000 shares for transaction amount of $11,326 was made by Wood Gavin (Chief Financial Officer) on 2022‑05‑20.
List of Insider Buy and Sell Transactions, Adaptimmune Therapeutics plc
| 2024-06-18 | Sale | Chief Commercial Officer | 24,531 0.0086% | $0.93 | $22,814 | +12.16% | ||
| 2024-01-17 | Sale | Chief Executive Officer | 30,080 0.0124% | $0.67 | $20,244 | +53.85% | ||
| 2024-01-17 | Sale | Chief Medical Officer | 18,276 0.0075% | $0.67 | $12,300 | +53.85% | ||
| 2024-01-17 | Sale | Chief Patient Supply Officer | 18,114 0.0075% | $0.67 | $12,191 | +53.85% | ||
| 2024-01-17 | Sale | Chief Operating Officer | 18,908 0.0078% | $0.67 | $12,725 | +53.85% | ||
| 2024-01-16 | Sale | Chief Executive Officer | 9,304 0.0046% | $0.79 | $7,350 | +54.20% | ||
| 2024-01-16 | Sale | Chief Patient Supply Officer | 4,681 0.0023% | $0.79 | $3,698 | +54.20% | ||
| 2024-01-16 | Sale | Chief Operating Officer | 4,681 0.0023% | $0.79 | $3,698 | +54.20% | ||
| 2024-01-16 | Sale | Chief Medical Officer | 2,287 0.0011% | $0.79 | $1,807 | +54.20% | ||
| 2024-01-12 | Sale | Chief Executive Officer | 17,257 0.0078% | $0.85 | $14,739 | +32.19% | ||
| 2024-01-12 | Sale | Chief Medical Officer | 7,799 0.0035% | $0.85 | $6,661 | +32.19% | ||
| 2024-01-12 | Sale | Chief Patient Supply Officer | 5,220 0.0024% | $0.85 | $4,458 | +32.19% | ||
| 2024-01-12 | Sale | Chief Operating Officer | 5,220 0.0024% | $0.85 | $4,458 | +32.19% | ||
| 2024-01-11 | Sale | Chief Executive Officer | 11,945 0.005% | $0.84 | $9,994 | +26.39% | ||
| 2024-01-11 | Sale | Chief Medical Officer | 4,009 0.0017% | $0.84 | $3,354 | +26.39% | ||
| 2024-01-11 | Sale | Chief Patient Supply Officer | 4,009 0.0017% | $0.84 | $3,354 | +26.39% | ||
| 2024-01-11 | Sale | Chief Operating Officer | 4,009 0.0017% | $0.84 | $3,354 | +26.39% | ||
| 2023-09-01 | Sale | Chief Executive Officer | 2,403 0.001% | $0.78 | $1,874 | +25.28% | ||
| 2023-08-01 | Sale | Chief Patient Supply Officer | 3,096 0.0013% | $0.91 | $2,804 | -5.26% | ||
| 2023-07-10 | Sale | director | 47,702 0.0283% | $0.91 | $43,447 | -5.56% |
Insider Historical Profitability
| Bertrand William C JR | Chief Operating Officer | 7785 0.003% | $0.64 | 1 | 18 | +23.78% |
| BARRIS PETER J | 10 percent owner | 82978668 32.4511% | $0.64 | 7 | 0 | <0.0001% |
| BARRETT M JAMES | 10 percent owner | 82978668 32.4511% | $0.64 | 7 | 0 | <0.0001% |
| KERINS PATRICK J | 10 percent owner | 82978668 32.4511% | $0.64 | 7 | 0 | <0.0001% |
| Viswanathan Ravi | 10 percent owner | 82978668 32.4511% | $0.64 | 7 | 0 | <0.0001% |
Institutional Investor Ownership
| Matrix Capital Management Company, L.P. | $61.58M | 15.25 | 38.97M | 0% | +$0 | 0.57 | |
| Ecor1 Capital Llc | $43.3M | 10.72 | 27.4M | New | +$43.3M | 0.3 | |
| Nea Management Company Llc | $26.99M | 6.68 | 17.08M | 0% | +$0 | 0.13 | |
| Baillie Gifford Co | $25.08M | 6.21 | 15.87M | -0.25% | -$63,618.70 | 0.02 | |
| Baker Bros Advisors LP | $17.04M | 4.22 | 10.79M | -1.66% | -$287,970.80 | 0.12 |